Resolving functional aggregates: A new perspective on innate immune control
解决功能聚集:先天免疫控制的新视角
基本信息
- 批准号:10456170
- 负责人:
- 金额:$ 123.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-30 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAmyloidAreaBiochemicalCellsChargeComplexCytoplasmic GranulesDisciplineDiseaseDissectionEnsureGoalsImmuneImmune responseImmune signalingInfectionInflammatoryInnate Immune ResponseInnate Immune SystemLaboratoriesMolecularNatural ImmunityNuclearPattern recognition receptorPhysiologyPositioning AttributeProteinsQuality ControlRNAResearchSignal TransductionSignaling MoleculeSystemTherapeuticWorkantimicrobialimmune functioninnate immune functioninnate immune mechanismsinterdisciplinary approachmacromolecular assemblymicrobialmisfolded proteinnovelpathogenprotein aggregationreconstitutionresponse
项目摘要
Pattern Recognition Receptors (PRRs) in the innate immune system form the first line of defense against a
broad range of pathogens. PRRs and their downstream signaling molecules often form aggregate-like
macromolecular assemblies and that they utilize such assemblies for their immunological functions. These
findings have transformed our understanding of how the innate immune system detects microbial infection and
how it activates the anti-microbial immune response. However, how these “functional aggregates” are
resolved upon their assembly to ensure transient activation of the potentially harmful inflammatory
signal is not known. How do these functional aggregates interact with the cellular protein quality control
(PQC) system, charged with resolving misfolded protein aggregates (e.g. amyloids)? Is there a commonality or
rather a divergence in cellular response to functional vs. dysfunctional misfolded aggregates? The current
application aims to address these questions by exploring the connections between innate immunity and PQC.
This is uncharted territory, with only few relevant studies that address such questions. Our strategy is to utilize
multidisciplinary approaches, from systematic functional screens to biochemical reconstitution and to structural
dissection. The combination of these approaches is sure to generate deep mechanistic understanding of how
functional aggregates in innate immunity are resolved. It will also provide a new paradigm for how the innate
immune system is regulated and how it can be further controlled for therapeutic gains. Furthermore,
considering the emerging view that many proteins form aggregates-like assemblies or granules as part of
normal physiology (e.g. cytosolic RNA granules and nuclear speckles), our findings and strategies have
implications far beyond the innate immune system.
The current application represents a new direction in my research. Unlike our previous and current work,
which has largely focused on the mechanisms of how microbial infection activates innate immune response,
this application focuses on the mechanisms of how cells turn off the immune signaling once activated. In
particular, I propose to explore the previously unappreciated interface between innate immunity and cellular
PQC, seeking new unifying principles governing both innate immune signaling complexes and misfolded
dysfunctional aggregates. Underlying this application is my general scientific approach of identifying novel
connections between disciplines and pushing the existing boundaries of the fields. While this proposal deals
with highly risky and challenging problems, as one of the pioneering laboratories for the discovery of functional
aggregates in innate immunity, I believe that we are uniquely positioned to open this new area of research.
先天免疫系统中的模式识别受体(PRR)形成了抵抗免疫缺陷的第一道防线。
广泛的病原体。PRR及其下游信号分子通常形成聚集体样
大分子组装体,并且它们利用这样的组装体用于它们的免疫功能。这些
这些发现改变了我们对先天免疫系统如何检测微生物感染的理解,
它是如何激活抗微生物免疫反应的然而,这些“功能性聚集体”是如何
在它们组装时决定,以确保瞬时激活潜在有害的炎性细胞,
信号是未知的。这些功能性聚集体如何与细胞蛋白质质量控制相互作用
(PQC)系统,负责解析错误折叠的蛋白质聚集体(例如淀粉样蛋白)?有没有共同点或者
而是细胞对功能性与功能失调性错误折叠聚集体的反应的分歧?当前
本申请旨在通过探索先天免疫和PQC之间的联系来解决这些问题。
这是一个未知的领域,只有很少的相关研究涉及这些问题。我们的策略是利用
多学科方法,从系统功能筛选到生化重建和结构
解剖这些方法的结合肯定会产生深刻的机械理解,
先天免疫中的功能聚集体被解决。它也将提供一个新的范例,
免疫系统的调节以及如何进一步控制免疫系统以获得治疗效果。此外,委员会认为,
考虑到新兴的观点,许多蛋白质形成聚集体样的组件或颗粒的一部分,
正常生理学(例如胞质RNA颗粒和核斑点),我们的发现和策略
其影响远远超出了先天免疫系统。
目前的应用代表了我研究的一个新方向。与我们以前和现在的工作不同,
其主要集中在微生物感染如何激活先天免疫应答的机制上,
本申请集中于细胞一旦被激活如何关闭免疫信号传导的机制。在
特别是,我建议探索先天免疫和细胞免疫之间以前未被重视的接口,
PQC,寻求新的统一原则,管理先天免疫信号复合物和错误折叠
功能失调的聚集体。这个应用程序的基础是我的一般科学方法,
学科之间的联系,并推动现有领域的边界。虽然这项提案涉及
高风险和具有挑战性的问题,作为一个开拓性的实验室,为发现功能
我相信,我们处于独特的地位,可以打开这一新的研究领域。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sun Hur其他文献
Sun Hur的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sun Hur', 18)}}的其他基金
Molecular mechanisms for antiviral signaling and regulation by MDA5 and TRIM65
MDA5 和 TRIM65 抗病毒信号传导和调节的分子机制
- 批准号:
10414029 - 财政年份:2020
- 资助金额:
$ 123.9万 - 项目类别:
Molecular mechanisms for antiviral signaling and regulation by MDA5 and TRIM65
MDA5 和 TRIM65 抗病毒信号传导和调节的分子机制
- 批准号:
10206037 - 财政年份:2020
- 资助金额:
$ 123.9万 - 项目类别:
Molecular mechanisms for antiviral signaling and regulation by MDA5 and TRIM65
MDA5 和 TRIM65 抗病毒信号传导和调节的分子机制
- 批准号:
10651722 - 财政年份:2020
- 资助金额:
$ 123.9万 - 项目类别:
Defining the molecular mechanism of Aire in T-cell tolerance
定义 Aire 在 T 细胞耐受中的分子机制
- 批准号:
9814890 - 财政年份:2019
- 资助金额:
$ 123.9万 - 项目类别:
Resolving functional aggregates: A new perspective on innate immune control
解决功能聚集:先天免疫控制的新视角
- 批准号:
10001442 - 财政年份:2019
- 资助金额:
$ 123.9万 - 项目类别:
Resolving functional aggregates: A new perspective on innate immune control
解决功能聚集:先天免疫控制的新视角
- 批准号:
10669648 - 财政年份:2019
- 资助金额:
$ 123.9万 - 项目类别:
Resolving functional aggregates: A new perspective on innate immune control
解决功能聚集:先天免疫控制的新视角
- 批准号:
10217977 - 财政年份:2019
- 资助金额:
$ 123.9万 - 项目类别:
Re-defining RIG-I-like helicases as viral RNA receptors with effector functions
将 RIG-I 样解旋酶重新定义为具有效应子功能的病毒 RNA 受体
- 批准号:
9296274 - 财政年份:2017
- 资助金额:
$ 123.9万 - 项目类别:
Interplays between ADAR1 and MDA5 in the pathogenesis of Aicardi-Goutière Syndrome
ADAR1 和 MDA5 在 Aicardi-Goutière 综合征发病机制中的相互作用
- 批准号:
9099769 - 财政年份:2015
- 资助金额:
$ 123.9万 - 项目类别:
Molecular Mechanisms for Antiviral Signal Activation by MDA5 and RIG-I
MDA5 和 RIG-I 激活抗病毒信号的分子机制
- 批准号:
9262830 - 财政年份:2014
- 资助金额:
$ 123.9万 - 项目类别:
相似国自然基金
基于聚金属氧酸盐对Amyloid蛋白的定点化学修饰及其在阿尔茨海默症治疗中的应用
- 批准号:
- 批准年份:2020
- 资助金额:63 万元
- 项目类别:面上项目
基于S1P通路探究Amyloid-β在干性年龄相关性黄斑变性中的作用
- 批准号:81870666
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
Amyloid-beta-PirB 相互作用介导小胶质细胞表型和功能变化参与AD进展的机制研究
- 批准号:81601123
- 批准年份:2016
- 资助金额:17.0 万元
- 项目类别:青年科学基金项目
Beta-amyloid寡聚体特有的抗原表位多肽疫苗的研究
- 批准号:30971012
- 批准年份:2009
- 资助金额:35.0 万元
- 项目类别:面上项目
抗阿兹海默病Beta-Amyloid寡聚物单链可变区抗体的筛选及其动物试验
- 批准号:30570622
- 批准年份:2005
- 资助金额:30.0 万元
- 项目类别:面上项目
相似海外基金
Elucidating the function of a protective protein in a novel in vitro reconstitution system for disaggregation of ubiquitinated amyloid fibrils
阐明保护蛋白在新型体外重构系统中用于解聚泛素化淀粉样蛋白原纤维的功能
- 批准号:
24K10522 - 财政年份:2024
- 资助金额:
$ 123.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
新規amyloid-β抑制因子ILEIの減少に伴うアルツハイマー病リスクと分子制御機構の解析
新型β淀粉样蛋白抑制剂ILEI降低相关阿尔茨海默病风险及分子调控机制分析
- 批准号:
23K06805 - 财政年份:2023
- 资助金额:
$ 123.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Extracting the detrimental effects of amyloid beta oligomer using contextual learning and controlling it with antagonist molecules
使用情境学习提取β淀粉样蛋白寡聚体的有害影响并用拮抗剂分子控制它
- 批准号:
23K06348 - 财政年份:2023
- 资助金额:
$ 123.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of inhibitors for amyloid peptide aggregation based on peptidomimetics
基于拟肽的淀粉样肽聚集抑制剂的开发
- 批准号:
23K14318 - 财政年份:2023
- 资助金额:
$ 123.9万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effect of abnormal beta-amyloid on Ca dynamics in neural cells
异常β-淀粉样蛋白对神经细胞钙动力学的影响
- 批准号:
23K14744 - 财政年份:2023
- 资助金额:
$ 123.9万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of novel functions of presenilin in ApoE secretion and brain amyloid removal
阐明早老素在 ApoE 分泌和脑淀粉样蛋白去除中的新功能
- 批准号:
23KF0156 - 财政年份:2023
- 资助金额:
$ 123.9万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Project 3: 3-D Molecular Atlas of cerebral amyloid angiopathy in the aging brain with and without co-pathology
项目 3:有或没有共同病理的衰老大脑中脑淀粉样血管病的 3-D 分子图谱
- 批准号:
10555899 - 财政年份:2023
- 资助金额:
$ 123.9万 - 项目类别:
Astrocytic exocytosis of ATP in amyloid pathology and Alzheimer's disease
淀粉样蛋白病理学和阿尔茨海默病中 ATP 的星形细胞胞吐作用
- 批准号:
10722422 - 财政年份:2023
- 资助金额:
$ 123.9万 - 项目类别:
Probing Amyloid Fibril Self-Assembly with Network Hamiltonian Simulations in Explicit Space
用显式空间中的网络哈密顿模拟探测淀粉样蛋白原纤维的自组装
- 批准号:
10715891 - 财政年份:2023
- 资助金额:
$ 123.9万 - 项目类别:
Preservation of brain NAD+ as a novel non-amyloid based therapeutic strategy for Alzheimer’s disease
保留大脑 NAD 作为阿尔茨海默病的一种新型非淀粉样蛋白治疗策略
- 批准号:
10588414 - 财政年份:2023
- 资助金额:
$ 123.9万 - 项目类别: